Trials / Completed
CompletedNCT01531218
Trial Of Azithromycin In Campylobacter Concisus Patients With Diarrhea
Randomized, Double-Blind, Placebo-Controlled Trial Of Azithromycin In Campylobacter Concisus Positive Patients With Diarrhea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, double-blind, placebo-controlled clinical trial of azithromycin in Campylobacter concisus culture positive patients with diarrhea. The clinical characteristics of emerging Campylobacter concisus in adults is vomiting and persistent diarrhea. Whether patients may benefit from antibiotic treatment is unknown. The purpose of this trial is to investigate whether antibiotic treatment with azithromycin of Campylobacter concisus induced diarrhea can better the symptoms and shorten the duration of illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azithromycin | azithromycin, oral use, 500mg per day for 3 days in total. Total dose 1500mg |
| DRUG | Placebo |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2012-02-10
- Last updated
- 2014-07-04
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01531218. Inclusion in this directory is not an endorsement.